查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1986803

子宮頸癌診斷市場報告：按檢測類型、年齡層和地區分類（2026-2034 年）

Cervical Cancer Diagnostics Market Report by Test Type (Pap Testing, HPV Testing, Cervical Biopsies, Colposcopy, and Others), Age Group (20 to 35 Years, Above 35 Years), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年全球子宮頸癌診斷市場規模達87億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到128億美元，2026年至2034年的複合年成長率為4.38%。

子宮頸癌的診斷依賴一系列先進的臨床檢測、儀器和程序，以評估異常細胞和人類乳突病毒（HPV）病毒株。這些檢測包括使用電極環採集組織樣本，在錐形切除術、穿刺切片檢查、子宮頸刮宮術和陰道鏡檢查過程中對子宮頸進行詳細檢查。一旦檢測到異常，則需進行進一步檢查，例如血液檢查、胸部X光片、全身電腦斷層掃描（CT）、磁振造影（MRI）、正子斷層掃描（PET）以及膀胱和直腸的視診，以確定疾病進展的階段。

性行為感染（STI）病例（如梅毒、披衣菌感染、淋病和後天免疫力缺乏缺乏症候群（HIV/AIDS））的診斷人數顯著增加，導致全球HPV感染風險上升。此外，吸菸率的上升（吸菸會增加罹患子宮頸癌的風險）也是推動市場成長的主要因素之一。同時，人們對早期診斷意識的提高促進了HPV家用檢測套組的廣泛使用，這些試劑盒能夠提供快速準確的檢測結果。有利的保險報銷方案也支持了市場成長。此外，人們對個人化治療方案的需求日益成長，也擴大了對子宮頸癌診斷的需求。而且，包括手術、放射線治療、化療、切除術、免疫療法和切除術在內的多種治療方案的出現，也促進了市場成長。此外，對開發低成本、高效檢測產品的日益重視，預計將進一步加速市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章：引言

第5章：全球子宮頸癌診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依測試類型分類

  • 巴氏抹片檢查
  • HPV檢測
  • 子宮頸切片檢查
  • 陰道鏡檢查
  • 其他

第7章 市場區隔：依年齡層別分類

  • 20-35歲
  • 35歲以上

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott Laboratories
    • Arbor Vita Corporation
    • Becton, Dickinson and Company
    • Cooper Surgical Inc.
    • F. Hoffmann-La Roche AG
    • Guided Therapeutics Inc.
    • Hologic Inc.
    • Qiagen
    • Quest Diagnostics Incorporated
    • Siemens Healthcare GmbH
Product Code: SR112026A3175

The global cervical cancer diagnostics market size reached USD 8.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.38% during 2026-2034.

Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (HPV). They are performed by taking a sample of the tissue obtained through conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, tests like blood, chest X-ray, body computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan and visual examination of bladder and rectum are conducted to determine the disease stage.

A considerable rise in the number of individuals diagnosed with sexually transmitted infections (STIs), such as syphilis, chlamydia, gonorrhea and acquired immune deficiency syndrome (HIV/AIDS), is escalating the risk of HPV infection worldwide. This, along with the growing number of smokers, which increases the chances of developing cervical cancer, represents one of the key factors bolstering the market growth. Furthermore, the rising awareness about early diagnosis is encouraging the adoption of HPV home testing kits that provide quick and accurate test results. The presence of favorable reimbursement policies also supports the market growth. Apart from this, rising preferences for personalized treatment plans are escalating the demand for cervical cancer diagnostics . Additionally, the availability of a range of other treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy and trachelectomy, is contributing to the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is anticipated to fuel the market growth.

KEY MARKET SEGMENTATION:

Breakup by Test Type:

  • Pap Testing
  • HPV Testing
  • Cervical Biopsies
  • Colposcopy
  • Others

Breakup by Age Group:

  • 20 to 35 years
  • Above 35 years

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the global cervical cancer diagnostics market?

2. What is the expected growth rate of the global cervical cancer diagnostics market during 2026-2034?

3. What are the key factors driving the global cervical cancer diagnostics market?

4. What has been the impact of COVID-19 on the global cervical cancer diagnostics market?

5. What is the breakup of the global cervical cancer diagnostics market based on the test type?

6. What are the key regions in the global cervical cancer diagnostics market?

7. Who are the key players/companies in the global cervical cancer diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cervical Cancer Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Pap Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 HPV Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cervical Biopsies
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Colposcopy
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 20 to 35 years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Above 35 years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Arbor Vita Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Becton, Dickinson and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Cooper Surgical Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Guided Therapeutics Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Hologic Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Qiagen
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Quest Diagnostics Incorporated
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Siemens Healthcare GmbH
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Cervical Cancer Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Cervical Cancer Diagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Cervical Cancer Diagnostics Market: Breakup by Test Type (in %), 2025
  • Figure 5: Global: Cervical Cancer Diagnostics Market: Breakup by Age Group (in %), 2025
  • Figure 6: Global: Cervical Cancer Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Cervical Cancer Diagnostics (Pap Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Cervical Cancer Diagnostics (Pap Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Cervical Cancer Diagnostics (HPV Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Cervical Cancer Diagnostics (HPV Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Cervical Cancer Diagnostics (Colposcopy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Cervical Cancer Diagnostics (Colposcopy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Cervical Cancer Diagnostics (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Cervical Cancer Diagnostics (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Cervical Cancer Diagnostics (20 to 35 years) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Cervical Cancer Diagnostics (20 to 35 years) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Cervical Cancer Diagnostics (Above 35 years) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Cervical Cancer Diagnostics (Above 35 years) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: North America: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: North America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: United States: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: United States: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Canada: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Canada: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Asia-Pacific: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Asia-Pacific: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: China: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: China: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Japan: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Japan: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: India: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: India: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: South Korea: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: South Korea: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Australia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Australia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Indonesia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Indonesia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Europe: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Europe: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Germany: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Germany: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: France: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: France: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: United Kingdom: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: United Kingdom: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Italy: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Italy: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Spain: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Spain: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Russia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Russia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Latin America: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Latin America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Brazil: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Brazil: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Mexico: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Mexico: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Middle East and Africa: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Middle East and Africa: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Middle East and Africa: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 70: Global: Cervical Cancer Diagnostics Industry: SWOT Analysis
  • Figure 71: Global: Cervical Cancer Diagnostics Industry: Value Chain Analysis
  • Figure 72: Global: Cervical Cancer Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cervical Cancer Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 3: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Age Group (in Million USD), 2026-2034
  • Table 4: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Cervical Cancer Diagnostics Market: Competitive Structure
  • Table 6: Global: Cervical Cancer Diagnostics Market: Key Players